Assistant Professor, Internal Medicine, University of Michigan Medical School
Hematology
Dr. John M. Magenau IV, MD
|
|
Give Review
John M. Magenau IV, MD practices Hematology. He attended University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago is ranked 49/85 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". John Magenau is a published doctor and has 17 publications published. The lastest was: 'Analytic morphomics: a novel CT imaging approach to quantify adipose tissue and muscle composition in allogeneic hematopoietic cell transplantation.' John Magenau accepts Medicare.
Publications
- Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
- Analytic morphomics: a novel CT imaging approach to quantify adipose tissue and muscle composition in allogeneic hematopoietic Cell transplantation.
- Reducing Treatment-related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A Universi...
- FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.
- Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for Acute myeloid leukemia in rem...
- Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung.
- A PROGNOSTIC SCORE FOR Acute GRAFT-VERSUS-HOST DISEASE BASED ON BIOMARKERS: A MULTICENTER STUDY.
- Proteasome: target for Acute and chronic GVHD?
- Engraftment Syndrome after Allogeneic Hematopoietic Cell Transplantation Predicts Poor Outcomes.
- Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
- Next Generation Treatment of Acute Graft-versus-Host Disease.
- The Difficulty in Diagnosing Cord Colitis.
- Vorinostat plus tacrolimus and mycophenolate to prevent Graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell ...
- Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: To Whom, When, and How.
- Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for Acute graft-versus-host-disease.
- New targets for therapy of sarcoma.
Schools
Temple University
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
University of Illinois College of Medicine at Chicago -
Temple University School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Helpful Reviews
Similar Doctors
|
|
Dr. Asra Z. Ahmed, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale L. Bixby, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Norah L. Henry, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lisa A. Kujawski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milind Velankar, MD |
|
|
Dr. Charles W. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colin J. Mooney, MD |
|
|
Dr. Daniel Lebovic, MD |
|
|
Dr. Sofia D. Merajver, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. George J. Brewer, MD |
|
|
Dr. Jie Wang, MD |
|
|
Dr. Mary L. Varterasian, MD |